Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DA6T3R
|
|||
| Drug Name |
VLA1553
|
|||
| Drug Type |
Vaccine
|
|||
| Indication | Chikungunya virus infection [ICD-11: 1D40; ICD-9: 001-139, 042-075] | Phase 3 | [1] | |
| Company |
Valneva
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04838444) Antibody Persistence And Long Term Safety Of A Chikungunya Virus Vaccine Candidate (VLA1553). U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.